The latest report by IMARC Group, titled “Iron Deficiency Injectables Market Report by Product Type (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, and Others), Indication (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, and Others), Branded/Generics (Branded, Generics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032“, The global iron deficiency injectables market size reached US$ 13.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 36.9 Billion by 2032, exhibiting a growth rate (CAGR) of 11.78% during 2024-2032.

Iron deficiency injectables are a type of intravenous (IV) medications used to treat iron deficiency by directly administering IV drugs into an individual's bloodstream. This results in the production of red blood cells (RBCs) more quickly as compared to oral medications. They are typically prescribed to patients with severe iron deficiency or, in cases requiring rapid improvement in hemoglobin levels due to their fast-acting nature. They help reduce non-compliance, poor adherence, and adverse gastrointestinal effects often associated with oral drugs. They also promote quicker absorption of the infused supplements. As a result, iron deficiency injectables are gaining immense traction among healthcare professionals across the globe for treating severe deficiency cases. 

Iron Deficiency Injectables Market Trends and Drivers:

The global iron deficiency injectables market is primarily driven by the increasing prevalence of iron deficiency anemia. Moreover, the rising use of iron deficiency injectables to treat anemia before the occurrence of medical complications, especially among pregnant women who are at increased risk of premature birth and maternal deaths, is positively influencing the market growth. Additionally, the surging incidences of chronic conditions, such as kidney disorders and cancer, and the expanding geriatric population have catalyzed the market growth. Furthermore, numerous technological advancements in intravenous iron drugs aimed at improving injectable functional capacity and enhancing iron restoration in people suffering from iron deficiency anemia are contributing to market growth. Other factors, including improving diagnosis rates, the launch of dextran-free intravenous formulations, and increasing investments in the healthcare sector, are also anticipated to propel the market growth.  

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/iron-deficiency-injectables-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Iron Dextran
  • Iron Sucrose
  • Ferric Carboxymaltose
  • Others

Breakup by Indication:

  • Chronic Kidney Disease
  • Inflammatory Bowel Disease
  • Cancer
  • Others

Breakup by Branded/Generics:

  • Branded
  • Generics

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • AbbVie Inc.
  • BSA Pharma Inc.
  • Covis Pharma GmbH
  • CSL Vifor (CSL Limited)
  • Daiichi Sankyo Company Limited
  • Pharmacosmos A/S
  • Sandoz AG
  • Sanofi S.A.
  • Systacare Remedies

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163